Rose McCormack is a highly accomplished pharmaceutical professional with extensive experience in research, clinical biomarker science, and diagnostic team direction. She has a proven track record of success at AstraZeneca, having held positions as Senior Research Scientist, Clinical Biomarker Scientist, Diagnostic Team Director, and Director of Global Products. Today, she serves as the Global Product Leader at AstraZeneca, using her expertise to develop and promote new pharmaceutical products around the world.

McCormack's academic credentials include a Ph.D. in Genetics from Queen's University Belfast, an MMedSc in Medical Laboratory Science from Queen's University Belfast, and a BSc in Analytical Science from Dublin City University. She is a respected thought leader in the pharmaceutical industry, and she brings an analytical mindset and attention to detail to all of her work.

In her role as Global Product Leader, McCormack is responsible for developing and launching new products, driving revenue growth, and overseeing global marketing efforts. She is a skilled communicator with a strong understanding of international markets, and she is known for her ability to build positive relationships with stakeholders at all levels.

Overall, Rose McCormack is a skilled and knowledgeable pharmaceutical professional with deep expertise in product development, clinical biomarker science, and diagnostic team direction. Her academic credentials and extensive experience at AstraZeneca make her an invaluable asset to the company and a respected thought leader in the industry.